Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD.

E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), Y. Shoykhet (Barnaul, Russian Federation), A. Balitskya (Barnaul, Russian Federation), V. Yarkova (Tyumen, Russian Federation), V. Nikitin (Yoshkar-Ola, Russian Federation)

Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Session: Cardiovascular comorbidities in COPD
Session type: Thematic Poster
Number: 2662
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), Y. Shoykhet (Barnaul, Russian Federation), A. Balitskya (Barnaul, Russian Federation), V. Yarkova (Tyumen, Russian Federation), V. Nikitin (Yoshkar-Ola, Russian Federation). Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD.. 2662

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Prognostic value of right ventricular systolic dysfunction in patients with chronic obstructive pulmonary disease after ST-segment elevation myocardial infarction (STEMI).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Heart remodeling in patients after St-segment elevation myocardial infarction with and without concomitant COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


COPD and acute myocardial infarction
Source: Eur Respir Rev, 29 (156) 190139; 10.1183/16000617.0139-2019
Year: 2020



OSA and myocardial infarction
Source: ERS Conference
Year: 2015

High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction
Source: Eur Respir J 2005; 26: Suppl. 49, 218s
Year: 2005

Clinical features of hospital-aquired pneumonia in patients with myocardial infarction
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008


Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD
Source: Eur Respir J 2012; 39: 1097-1103
Year: 2012



COPD in patients evaluated for stable myocardial ischemia – observational study
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




Exacerbation frequency and increased risk of myocardial infarction in COPD
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Sleep quality of patients with acute myocardial infarction outside the CCU environment
Source: Eur Respir J 2006; 28: Suppl. 50, 633s
Year: 2006

Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019


Assessment of respiratory muscle function in post-myocardial infarction patients: Preliminary results
Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting
Year: 2010

Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019


The impact of tobacco cessation on the evolution of patients with non-ST-elevation acute coronary syndromes.
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Effects of nebivolol and ivabradine on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


Acute myocardial infarction is associated with increased number of bronchial macrophages in low risk patients
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Respiratory muscle trainings in patients after myocardial infarction with concomitant heart failure
Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease
Year: 2010

Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018